|
Synonyms: 3,4-dihydroxy-L-phenylalanine | Inbrija® (levodopa inhalation powder) | L-DOPA | Sinemet®
levodopa is an approved drug (FDA (1993), EMA (2003))
Compound class:
Metabolite
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| Used in the treatment of Parkinson's disease. The 2003 EMA approval authorises the use of levodopa in a fixed-dose combination with carbidopa and entacapone (called Stalevo®). The EMA has also approved a combination containing just levodopa and carbidopa (Numient®, 2015). |
External links ![]() |
|
For extended ADME data see the following: European Medicines Agency (EMA) |